Investors Aim to Advance Basecamp Research Toward Clinical Trials
Investors are pushing Basecamp Research to move from protein and biodiversity data infrastructure toward human clinical trials, the Wall Street Journal reports.
Topic
Clinical Trials
Topic
Clinical Trials
Sobi's $75 Million Upfront Buys Innate Pharma Time Until 2028
Innate Pharma closed its lacutamab deal with Sobi, triggering a $75 million upfront payment and a funding runway into Q1 2028 des…
Longeveron's Heart Drug Misses Phase 2b Goal, Triggering Strategic Review
Longeveron's ELPIS II Phase 2b trial of laromstrocel in HLHS infants missed its primary endpoint. The company has launched a stra…